Oncology & Cancer

New prostate cancer test more specific, sensitive than PSA test

A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional ...

Health

AUA: Marijuana tied to increased risk for LUTS medications in BPH

(HealthDay)—Marijuana use is associated with both sperm functional defects and an increased risk for being on a lower urinary tract symptom (LUTS) medication among men with benign prostatic hyperplasia (BPH)/LUTS, according ...

Diseases, Conditions, Syndromes

Research points to new treatment for prostate condition

An unexpected discovery by scientists at the University of York could potentially pave the way for new treatments for benign enlargement of the prostate, a condition which affects more than 200 million men worldwide.

Oncology & Cancer

Novel MRI-guided ultrasound treatment destroys prostate cancer

A novel MRI-guided procedure that uses therapeutic ultrasound effectively treats prostate cancer with minimal side effects, according to a new study presented today at the annual meeting of the Radiological Society of North ...

Diseases, Conditions, Syndromes

High doses of saw palmetto appear safe over 18 months

(HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.

Medications

Popular prostate drug linked to serious side effects

Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening ...

page 2 from 7